Recursion Pharmaceuticals
Artikel ini sebatang kara, artinya tidak ada artikel lain yang memiliki pranala balik ke halaman ini. Bantulah menambah pranala ke artikel ini dari artikel yang berhubungan. (April 2025) |
| Kode emiten | Nasdaq: RXRX |
|---|---|
| Situs web | www |
Recursion Pharmaceuticals adalah perusahaan bioteknologi tahap klinis yang berfokus pada pemetaan dan decoding biologi dengan mengintegrasikan inovasi teknologi di seluruh biologi, kimia, otomatisasi, ilmu data, dan teknik.[1][2][3]
Perusahaan ini berkantor pusat di Salt Lake City, Utah . Didirikan oleh Chris Gibson, Dean Li dan Blake Borgeson.[4][5]
Referensi
- ^ Cornall, Jim (2022-09-14). "Recursion adds FAP and C. diff clinical trials". Labiotech.eu (dalam bahasa American English). Diakses tanggal 2024-07-29.
- ^ "Recursion Pharma".
- ^ Coleman, Julie (2024-05-10). "Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly". CNBC (dalam bahasa Inggris). Diakses tanggal 2024-07-29.
- ^ Gibson, Chris (2023-07-20). "How Chris Gibson founded Recursion Pharmaceuticals". Utah Business (dalam bahasa American English). Diakses tanggal 2024-07-29.
- ^ "Board of Directors - Recursion".
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.